Return to Home [X]

Exciting News: Introducing the New Essential Evidence Plus!

We are thrilled to announce that a brand-new version of Essential Evidence Plus is on its way! Mark your calendars for the launch date, September 11th, as we are introducing a modern, mobile-first application that will revolutionize your experience. With this update, accessing our valuable content will be easier and more convenient than ever before.

What to Expect from the New Essential Evidence Plus:

  1. Modern Mobile-First Experience: Our new application has been meticulously designed with a mobile-first approach. No matter what device you're using, whether it's a smartphone, tablet, or desktop, you'll enjoy a seamless and intuitive user experience.
  2. Enhanced Accessibility: We understand the importance of accessing content from anywhere, at any time. The new Essential Evidence Plus will provide you with the flexibility to explore our extensive collection of evidence-based resources on the go, making it easier to stay up to date with the latest medical knowledge and interactive tools.
  3. Improved User Interface: We have revamped our user interface to ensure effortless navigation and a visually appealing experience. Finding the information, you need will be quicker and more intuitive, saving you valuable time and effort.

Essential Evidence Plus will be available to users during this transition. However, please note that ability to create new trial and individual subscriptions will not be available from September 8th to September 11th 7:00 AM EST. During this period, we will be working diligently to transfer our existing system to the upgraded platform, ensuring a seamless transition for all users.

We apologize for any inconvenience caused by this temporary interruption. Rest assured, our team is committed to bringing you a superior user experience, and we appreciate your patience and understanding during this time.

Stay Tuned for the New Essential Evidence Plus!

We are counting down the days until September 11th when the new Essential Evidence Plus will be available for you to explore. Get ready to unlock a wealth of evidence-based resources that empower you in your medical decision-making process.

Thank you for your continued support, and we look forward to delivering an exceptional experience with the all-new Essential Evidence Plus!

Essential Evidence Plus

Accreditation Statements

AMA PRA Category 1 Credit™

John Wiley & Sons designates this website for a maximum of 20 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

John Wiley & Sons, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

In order to successfully complete this activity, physicians must complete a three-step learning cycle, as follows: 1) review original clinical question(s); 2) identify the relevant sources from among those consulted; and 3) describe the application of their findings to practice.

Physicians may claim a half (0.5) AMA PRA Category 1 Credit™ for conducting a single structured online search on a clinical topic. Physicians may claim up to a limit of twenty (20) AMA PRA Category 1 Credits™ per year (or 40 searches at 0.5 credit per search).

Mainpro+® credit

This Self-learning program [POEMs (Patient Oriented Evidence that Matters) CPD Program] has been certified by the College of Family Physicians of Canada for up to 26 Mainpro+ credits.

Physicians may claim 1 Mainpro+ credit per hour for studying a Daily POEM and completing a structured Information Assessment Method questionnaire reflecting on the impact of the research on their practice.

Goals and Objectives

Goal: Improve clinical decision-making and associated patient care outcomes by providing physicians with evidence-based information relevant to their clinical questions.

Objectives: As a result of this educational activity, the participant will be able to:

  1. 1. Access and apply validated information that can enhance their decision-making in specific instances of diagnosis and treatment.
  2. 2. Engage in structured, self-directed reflection on the question, the evidence, and the application of information to a particular clinical case.

This program has received financial support from Wiley in the form of an annual honorarium to EE+ editors of Patient-Oriented-Evidence that Matters (POEMs).

Potential for conflict(s) of interest:

Henry Barry, Mark Ebell, Nita Shrikant Kulkarni, Allen Shaughnessy, David Slawson and Linda Speer, editors of Patient-Oriented-Evidence that Matters (POEMs) receive an annual honorarium from Wiley, who publish 13/102 (13%) of the journals for which papers are selected for inclusion as POEMs. Erik Lindbloom, peer reviewer for POEMs receives an annual honorarium from Wiley. They have no other relevant financial relationships to disclose. Scientific planning committee members for POEMS, Roland Grad, Diane Kelsall and Naomi Pliamm receive an honorarium from Joule Inc. for their participation in the Scientific Planning Committee for POEMs. Diane Kelsall has a contract with the Canadian Medical Association as Editor for CMAJ Open and Consulting Editor for CMAJ Open and Naomi Pliamm, has worked with a variety of pharmaceutical companies and educational/physician organizations to moderate events, train representatives and provide feedback on programs/content. They have no other relevant financial relationships to disclose.

Mitigating potential bias:

Selection of papers for POEMs is overseen by Erik Lindbloom and his team of peer reviewers. Erik Lindbloom receives an annual honorarium from Wiley. He has no other relevant financial relationships to disclose.